欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/2251/001
药品名称Duodart 0,5 mg / 0,4 mg Hartkapseln
活性成分
    • Dutasteride 0.5 mg
    • Tamsulosin hydrochloride 0.4 mg
剂型Capsule, hard
上市许可持有人GlaxoSmithKline GmbH & Co. KG Prinzregentenplatz 9 8 1675 München Germany
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Belgium (BE)
    • Luxembourg (LU)
    • Iceland (IS)
    • Ireland (IE)
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Greece (GR)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Lithuania (LT)
      Combodart 0,5 mg/0,4 mg kietosios kapsulės
    • Hungary (HU)
      DUODART 0,4 mg/0,5 mg kemény kapszula
    • Bulgaria (BG)
      Duodart
    • Cyprus (CY)
      DUODART 0,5mg/0,4mg HARD CAPS
    • Czechia (CZ)
      Duodart
    • Romania (RO)
      Duodart 0,5/0,4 mg capsule
    • Slovakia (SK)
      Duodart
    • Slovenia (SI)
    • Malta (MT)
    • Netherlands (NL)
    • Latvia (LV)
    • Estonia (EE)
    • Portugal (PT)
许可日期2010/03/29
最近更新日期2024/10/08
药物ATC编码
    • G04CA52 tamsulosin and dutasteride
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Fixed combination Art 10b Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase